Legislators plan to uphold 2015 ICD-10 implementation

While some healthcare organizations are pushing for a two-year delay to the Oct. 1, 2015, ICD-10 implementation date, two House committee leaders issued a joint statement expressing their support for maintaining the deadline for the transition.

The Medical Society of the State of New York, the Texas Medical Association and the National Physicians' Council for Healthcare Policy sent a letter to House Speaker John Boehner (R-Ohio) asking him to delay the ICD-10 implementation until October 2017.

The groups urged Boehner to work with House Rules Committee Chair Pete Sessions (R-Texas) and House Energy and Commerce Committee Chair Fred Upton (R-Mich.) "to have this [delay] added to a must-pass piece of legislation during the upcoming Lame Duck Session in 2014."

Instead, a continuing resolution omnibus spending bill, or "cromnibus," to fund most of the federal government failed to contain language delaying ICD-10. The House narrowly approved the bill on Dec. 11.

Upton and Sessions said the House Energy and Commerce Committee "has been working with CMS to ensure the Oct. 1, 2015, implementation is achieved" and acknowledged they have heard from several stakeholders concerned about the industry's readiness to comply with ICD-10 and thanked those groups and individuals "for opening up this dialogue and expressing their thoughts and concerns regarding this issue."

The lawmakers said they are prepared to hold a congressional hearing on ICD-10 implementation progress in the new year. "It is our priority to ensure that we continue to move forward in healthcare technology and do so in a way that addresses the concerns of all those affected and ensure that the system works."

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.